Carol Miao, PhD, on Delivering Gene Editing Tools With Nonviral Methods in Hemophilia A Models
May 28th 2023The principal investigator at Seattle Children’s Research Institute discussed her lab’s preclinical research on nonviral delivery methods for gene editing tools in the context of treating hemophilia A.
Carol Miao, PhD, on Exploring New Delivery Methods for Gene Replacement Therapy and Gene Editing
May 26th 2023The principal investigator at Seattle Children’s Research Institute discussed the preclinical research on delivery methods for genomic medicines that her lab presented at ASGCT’s 2023 meeting.
Arshad Khanani, MD, on 4D-150’s Ability to Address Treatment Burden in Wet AMD
May 9th 2023The director of clinical research at Sierra Eye Associates discussed the latest results from a clinical trial evaluating 4D Molecular Therapeutics’ gene therapy, 4D-150, that were presented at ARVO’s 2023 conference.